Appendix 3Excluded Studies
View in own window
| Reference | Reason for Exclusion |
|---|
| IWASAKI et al. Diabetology International 2017;8(2):228-36 | Non-RCT |
KADOWAKI et al. Diabetology International 2017;8(1):87-94
FULCHER et al. Diabetes Technol Ther 2016;18()(pp S49-S50), 2016. S49-S50
HARRIS et al. Diabetes Obes Metab 2017;19(6):858-65
ONISHI et al. J 2017;diabetes investig.. 8(2):210-7
KADOWAKI et al. J 2016;diabetes investig.. 7(5):711-7
FRANEK et al. Diabet Med 2016;33(4):497-505
KANEKO et al. Diabetes Res Clin Pract 2015;107(1):139-47
FULCHER et al. Diabetes Care 2014;37(8):2084-90
MATHIEU et al. Diabetes Obes Metab 2014;16(7):636-44
NISKANEN et al. Eur 2012;J. ENDOCRINOL.. 167(2):287-94 | Comparator not of interest |
KAHL. Diabetologe 2016;12(3):201-2
GOUGH et al. Diabetes Technol Ther 2014;16(Suppl 1):S37-S38
RODBARD et al. Diabetes Obes Metab 2014;16(9):869-72 | Review |
YAMADA et al. Diabetology International 2014;5(1):74-7
KOMURO et al. J Diabetes Sci Technol 2015;9(3):632-8
KOEHLER et al. Diabetologia 2014;57(1):40-9
IGA et al. Diabetes Ther 2017; | Short duration |
LINJAWI et al. Diabetes Ther 2017;8(1):101-14
KUMAR et al. Diabet Med 2017;34(2):180-8
HIRSCH et al. Diabet Med 2017;34(2):167-73
RODBARD et al. Diabet Med 2017;34(2):189-96
KUMAR et al. PLoS ONE 2016;11(10):e0163350, 2016
LINGVAY et al. JAMA 2016;315(9):898-907
GOUGH et al. Diabetes Obes Metab 2015;17(10):965-73
GOUGH et al. Lancet Diabetes Endocrinol 2014;2(11):885-93
BUSE et al. Diabetes Care 2014;37(11):2926-33
ONISHI et al. Diabetes Obes Metab 2013;15(9):826-32
HIRSCH et al. Diabetes Care 2012;35(11):2174-81
HEISE et al. Diabetes Care 2011;34(3):669-74
HOME et al. Diabet Med 2012;29(6):716-20 | Intervention not of interest (fixed dose combo) |
IWAMOTO et al. J 2013;diabetes investig.. 4(1):62-8
BIRKELAND et al. Diabetes Care 2011;34(3):661-5 | Phase II study |
| ZINMAN et al. Lancet Diabetes Endocrinol 2013;1(2):123-31 | Regimen not of interest (three times weekly) |
RCT = randomized controlled trial.
